Tulieve Injection
Tulieve Injection is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antimicrobial agent, for the treatment of Bovine Respiratory Disease (BRD) and Swine Respiratory Disease (SRD).
Target Species: Beef cattle, pigs
-
Active Ingredient
Tulathromycin 100mg/mL
-
Pharmaceutical Form
Solution for injection
-
Indications
Tulieve Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolyica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis sensitive to tulathromycin in cattle.
Tulieve Injection is indicated for the treatment of swine respiratory disease (SRD) associated with Pasteurella multocida, Mycoplasma hyopneumoniae, and Haemophilus parasuis sensitive to tulathromycin in pigs.
-
Dosage
Cattle: 1 mL/40 kg bodyweight (2.5mg tulathromycin/kg) by a subcutaneous injection high on the neck. For cattle over 400kg bodyweight, divide the dose so that no more than 10mL are injected at one site.
Pigs: 1mL/40kg bodyweight (2.5mg tulathromycin/kg) by an intramuscular injection in the neck. For pigs over 100kg bodyweight, divide the dose so that no more than 2.5mL are injected at one site.
Prefer to speak directly to a member of our team?
Norbrook Laboratories Australia Pty Ltd.
We are open Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.